(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4...d other cancers are mainly caused by cigarette smo...the risk of cancer occurrence. In order to reduce ...n Tobacco company is in the process of testing //t...h they feel will reduce the carcinogen exposure to...
...ugh, which could eventually lead to a practical an...scientists from the US National Cancer Institute h...man body to produce chemicals that block HIV infec... on the surfaces of the gut and reproductive areas...
...ink has been established between age-related macul...ing the disease process. The finding has been conf...d Chlamydia pneumoniae in the diseased tissue of t...able that the microorganism is associated with chr...
... threat of bird flu in the famous Ranganathittu bi... Bangalore, Karnataka Forest Department today said...from migratory birds. // The Department has taken ...u as it is generally flocked by migratory birds fr...
Other Medicine News:Health News:Genetically modified bacteria to combat HIV 2Health News:Bird flu threat ruled out: Karnataka Forest Department, 2(Date:10/13/2008)... January 2009 and Final Trial .... 13 /- Neurobiological,Tec...nounced that following a,meeting with the U.S. Foo...TM) (ancrod) Phase 3 clinical program for acute is...d analyze data from its two concurrently,running d...
(Date:10/12/2008)...ewswire-FirstCall/ -- Boston,Scientific Corporatio...alysis,of nearly 7,500 patients from its TAXUS ARR...irm the performance of the TAXUS(R) Express2(TM),P...rld practice. The,two-year pooled ARRIVE data show...s in patients with diabetes as effectively as in p...
(Date:10/10/2008)...ll/ -- Boston Scientific,Corporation (NYSE: BSX )...or,events and press announcements at the Cardiovas... Transcatheter Cardiovascular Therapeutics (TCT),s... 17 in Washington, D.C., Boston Scientific will b...ata on its TAXUS(R) Express2(TM) and second-genera...
(Date:10/9/2008)...mber 2008, BOTHELL, Wash., Oct. 9 /PRNewswire-Fir...ced today the completion of patient enrollment and...to evaluate the safety and,efficacy of its formula...r,the over-the-counter (OTC) market. The Company e...l trial in November 2008. Ibuprofen is an analgesi...
Breaking Medicine Technology:Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 3Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Hill Rom to Present at the Citi Healthcare Conference 18778 15th Annual World Lupus Day Philadelphians Take Part In a Global Rally of Support 18775 15th Annual World Lupus Day Philadelphians Take Part In a Global Rally of Support 18775 2Met Pro Corporation to Report First Quarter Earnings on May 22 18772 1Met Pro Corporation to Report First Quarter Earnings on May 22 18772 2Met Pro Corporation to Report First Quarter Earnings on May 22 18772 3Mangos Captures 11 HMR Awards 18769 1Mangos Captures 11 HMR Awards 18769 2...BRIDGE, Mass.--(BUSINESS WIRE)--Apr 17, 2007 - Aln...ng RNAi therapeutics,company, announced today at t... 2007 Annual Meeting that it will advance a,system...the,treatment of liver cancer and potentially othe...SP01 is an RNAi therapeutic that is,designed to ta...
...TREAL & MALVERN, Pa.--(BUSINESS WIRE)--Apr 18,...f positive preclinical data,from a study of its le... lymphoblastic leukemia (ALL). The study was discu... of the American Association,for Cancer Research (...ed potent single agent activity against ALL blast ...
Other Medicine Technology:Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 2Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 3Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 4Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 5Gemin X Presents Positive Preclinical Data of GX15-070 in Infant,ALL at AACR Meeting 2Gemin X Presents Positive Preclinical Data of GX15-070 in Infant,ALL at AACR Meeting 3Humerus Fracture Brace indications: , Nonoperative treatment of closed humeral shaft fractures , Postoperative treatment of open humeral shaft fractures , Protection of humeral defects , After rem
The FUNCTIONAL ARM BRACE (FAB) was designed to allow immobilization in multiple positions to make it useful as a functional brace in early rehabilitation., ,Far more than an "Elbow ROM Brace" - the
Controls humeral segments through soft tissue compression while allowing for full range of elbow motion
...This simple concept is the cornerstone of our Town...k the heel with our patent-pending Stablelock Syst...t your patient will experience walking in their TS... and supports the posterior aspect of the leg. Thi...
Medicine Products: